Early detection of placental inflammation by MRI enabling protection by clinically relevant IL-1Ra administration

American Journal of Obstetrics and Gynecology

Volumn 206, Issue 4, 2012, Pages 358.e1-358.e9

  Girard, Sylvie ^a   Tremblay, Luc ^b   Lepage, Martin ^b   Sebire, Guillaume ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

inflammation; interleukin 1; magnetic resonance imaging; placenta

Indexed keywords

INTERLEUKIN 1BETA; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; MACROPHAGE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PLACENTA DISORDER; PLACENTITIS; PRIORITY JOURNAL; RAT; THERAPY DELAY; TISSUE INJURY; UPREGULATION;

EID: 84859421158     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2012.01.008     Document Type: Article

References (36)

1. Boksa P. Effects of prenatal infection on brain development and behavior: a review of findings from animal models. Brain Behav Immun 2010;24:881-97.
2. Bracci R, Buonocore G. Chorioamnionitis: a risk factor for fetal and neonatal morbidity. Biol Neonate 2003;83:85-96. (Pubitemid 36184381)
3. Larroque B, Ancel P-Y, Marret S, et al. Neurodevelopmental disabilities and special care of 5-year-old children born before 33 weeks of gestation (the EPIPAGE study): a longitudinal cohort study. Lancet 2008;371:813-20. (Pubitemid 351330166)
4. Atladóttir HO, Thorsen P, Østergaard L, et al. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord 2010;40:1423-30.
5. Brown AS, Derkits EJ. Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psychiatry 2010; 167:261-80.
6. Patterson PH. Maternal infection and immune involvement in autism. Trends Mol Med 2011;17:389-94.
7. Brehaut JC, Kohen DE, Raina P, et al. The health of primary caregivers of children with cerebral palsy: how does it compare with that of other Canadian caregivers? Pediatrics 2004; 114:182-91.
8. Fatemi SH, Folsom TD, Rooney RJ, et al. The viral theory of schizophrenia revisited: abnormal placental gene expression and structural changes with lack of evidence for H1N1 viral presence in placentae or brains of exposed offspring from infected mice. Neuropharmacology 2011. Epub ahead of print.
9. Liu H, Redline RW, Han YW. Fusobacterium nucleatum induces fetal death in mice via stimulation of TLR4-mediated placental inflammatory response. J Immunol 2007;179:2501-8.
10. Shi L, Tu N, Patterson PH. Maternal influenza infection is likely to alter fetal brain development indirectly: the virus is not detected in the fetus. Int J Dev Neurosci 2005;23:299-305. (Pubitemid 40313561)
11. Leviton A, Allred E, Kuban K, et al. Microbiologic and histologic characteristics of the extremely preterm infant's placenta predict white matter damage and later cerebral palsy: the ELGAN study. Pediatr Res 2010;67:95-101.
12. Chow SSW, Craig ME, Jones CA, et al. Differences in amniotic fluid and maternal serum cytokine levels in early midtrimester women without evidence of infection. Cytokine 2008; 44:78-84.
13. Shim S-S, Romero R, Hong J-S, et al. Clinical significance of intra-amniotic inflammation in patients with preterm premature rupture of membranes. Am J Obstet Gynecol 2004;191: 1339-45. (Pubitemid 39421594)
14. Girard S, Tremblay L, Lepage M, Sébire G. IL-1 receptor antagonist protects against placental and neurodevelopmental defects induced by maternal inflammation. J Immunol 2010;184:3997-4005.
15. Girard S, Kadhim H, Beaudet N, Sarret P, Sébire G. Developmental motor deficits induced by combined fetal exposure to lipopolysaccharide and early neonatal hypoxia/ischemia: a novel animal model for cerebral palsy in very premature infants. Neuroscience 2009; 158:673-82.
16. Yoon BH, Jun JK, Romero R, et al. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin- 1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol 1997; 177:19-26. (Pubitemid 27327305)
17. Yoon BH, Romero R, Park JS, et al. Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol 2000; 182:675-81. (Pubitemid 30207333)
18. Gowland P. Placental MRI. Semin Fetal Neonatal Med 2005;10:485-90. (Pubitemid 41188484)
19. Keevil SF, Gedroyc W, Gowland P, et al. Electromagnetic field exposure limitation and the future of MRI. Br J Radiol 2005;78:973-5. (Pubitemid 41684023)
20. Clements H, Duncan KR, Fielding K, Gowland PA, Johnson IR, Baker PN. Infants exposed to MRI in utero have a normal paediatric assessment at 9 months of age. Br J Radiol 2000;73:190-4. (Pubitemid 30179228)
21. Damodaram M, Story L, Eixarch E, et al. Placental MRI in intrauterine fetal growth restriction. Placenta 2010;31:491-8.
22. Fulford J, Gowland PA. The emerging role of functional MRI for evaluating fetal brain activity. Semin Perinatol 2009;33:281-8.
23. Linduska N, Dekan S, Messerschmidt A, et al. Placental pathologies in fetal MRI with pathohistological correlation. Placenta 2009;30: 555-9.
24. Messerschmidt A, Baschat A, Linduska N, et al. Magnetic resonance imaging of the placenta identifies placental vascular abnormalities independent of Doppler ultrasound. Ultrasound Obstet Gynecol 2011;37:717-22.
25. Ashdown H, Dumont Y, Ng M, Poole S, Boksa P, Luheshi GN. The role of cytokines in mediating effects of prenatal infection on the fetus: implications for schizophrenia. Mol Psychiatry 2006;11:47-55. (Pubitemid 43251087)
26. Fortier M-E, Luheshi GN, Boksa P. Effects of prenatal infection on prepulse inhibition in the rat depend on the nature of the infectious agent and the stage of pregnancy. Behav Brain Research 2007;181:270-7. (Pubitemid 46898665)
27. Redline RW. Severe fetal placental vascular lesions in term infants with neurologic impairment. Am J Obstet Gynecol 2005;192:452-7. (Pubitemid 40214979)
28. Smith SEP, Li J, Garbett K, Mirnics K, Patterson PH. Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci 2007; 27:10695-702. (Pubitemid 47535869)
29. Nicklin MJ, Hughes DE, Barton JL, Ure JM, Duff GW. Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene. J Exp Med 2000;191:303-12.
30. Bevilacqua MP, Pober JS, Wheeler ME, Cotran RS, Gimbrone MA. Interleukin-1 activation of vascular endothelium: effects on procoagulant activity and leukocyte adhesion. Am J Pathol 1985;121:394-403.
31. Warner SJ, Auger KR, Libby P. Interleukin 1 induces interleukin 1: II, recombinant human interleukin 1 induces interleukin 1 production by adult human vascular endothelial cells. J Immunol 1987;139:1911-7. (Pubitemid 17141623)
32. Berger CT, Recher M, Steiner U, Hauser TM. A patient's wish: anakinra in pregnancy. Ann Rheum Dis 2009;68:1794-5.
33. Schnitzler F, Fidder H, Ferrante M, et al. Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy. Inflamm Bowel Dis 2011;17:1846-54.
34. Carter JD, Ladhani A, Ricca LR, Valeriano J, Vasey FB. A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database. J Rheumatol 2009;36:635-41.
35. Miyamae T, Inaba Y, Nishimura G, et al. Effect of anakinra on arthropathy in CINCA/NOMID syndrome. Pediatr Rheumatol Online J 2010;8:9.
36. Neven B, Marvillet I, Terrada C, et al. Longterm efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/ chronic infantile neurologic, cutaneous, articular syndrome. Arthritis Rheum 2010;62:258-67.